Samsung Bioepis' Corporate Minority - II Round

Samsung Bioepis raised a round of funding on July 03, 2018. Investors include Biogen.

Samsung Bioepis develops high-quality biologic medicines that increase patient access to effective treatment.…

Articles about Samsung Bioepis' Corporate Minority - II Round: